Oncology Institute
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $119,802 | $104,406 | $100,267 | $99,901 |
Gross Profit | 15,696 | 17,249 | 14,636 | 14,366 |
EBITDA | -13,465 | -12,231 | -10,307 | -12,315 |
EBIT | -15,270 | -14,015 | -12,014 | -13,888 |
Net Income | -17,009 | -19,585 | -13,182 | -16,113 |
Net Change In Cash | 119,802 | 104,406 | 100,267 | 99,901 |
Free Cash Flow | -11,410 | -5,316 | 2,431 | 1,221 |
Cash | 30,292 | 39,739 | 49,669 | 47,402 |
Basic Shares | 932,036 | 77,099 | 75,655 | 75,524 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $393,412 | $324,239 | $252,483 | $203,003 |
Gross Profit | 53,997 | 59,573 | 52,093 | 40,848 |
EBITDA | -50,880 | -70,454 | 8,402 | -7,937 |
EBIT | -57,167 | -76,327 | 3,991 | -11,278 |
Net Income | -64,663 | -83,068 | 152 | -10,927 |
Net Change In Cash | 393,412 | 324,239 | 252,483 | 203,003 |
Cost of Revenue | -101,164 | 891 | ||
Free Cash Flow | -30,327 | -40,882 | -67,285 | -35,727 |
Cash | 49,669 | 33,488 | 14,010 | 114,299 |
Basic Shares | 75,043 | 73,748 | 80,605 | 66,230 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.15 |
2025-03-31 | -$0.20 |
2024-12-31 | -$0.14 |
